Health
Climate, COVID and corporate tax on the G-20 agenda in Rome
The leaders of the world’s economic powerhouses gathered Saturday for the first in-person summit since the coronavirus pandemic, with climate change, COVID-19 ...U.S. FDA authorizes Pfizer COVID-19 vaccine for kids 5 to 11
The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc (PFE.N) and BioNTech SE coronavirus vaccine for children aged 5 to 11 ...COVID infections, deaths dropping across the Americas -health agency
COVID-19 is slowly retreating across most of North, Central and South America, the Pan American Health Organization (PAHO) said on Wednesday, reporting ...U.S. readies plan to vaccinate kids ages 5-11 against COVID-19
The Biden administration on Wednesday outlined its plan to vaccinate millions of U.S. children ages 5 to 11 as soon as the ...U.S. workers face layoffs as U.S COVID-19 vaccine mandates kick in
Thousands of unvaccinated workers across the United States are facing potential job losses as a growing number of states, cities and private ...WHO-led program aims to buy antiviral COVID-19 pills for $10
A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to secure antiviral ...Life after COVID: EU re-thinks budget rules for new era
By Jan Strupczewski Reuters So often the source of rows between its members, the European Union starts reviewing its rules for national ...“Most locked-down city” Melbourne easing curbs as Australian state nears vaccination goal
Melbourne, which has spent more time under Covid-19 lockdowns than any other city in the world, is set to lift its stay-at-home ...WHO says it may be ‘last chance’ to find COVID origins
The World Health Organization (WHO) said on Wednesday its newly formed advisory group on dangerous pathogens may be “our last chance” to ...Merck seeks first U.S. authorization for COVID-19 tablet
Merck & Co Inc (MRK.N) said on Monday it has applied for U.S. emergency use authorization for its tablet to treat mild-to-moderate patients of ...














